{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:56Z","timestamp":1790188316277,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-05436-w","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T09:37:20Z","timestamp":1736847440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical outcome of BCG treatment for patients with urothelial carcinoma of the prostatic urethra: Implications for early cystectomy"],"prefix":"10.1007","volume":"43","author":[{"given":"Ryo","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Notsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shinsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Niwakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"5436_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","volume":"179","author":"HW Herr","year":"2008","unstructured":"Herr HW, Morales A (2008) History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 179:53\u201356. https:\/\/doi.org\/10.1016\/j.juro.2007.08.122","journal-title":"J Urol"},{"key":"5436_CR2","unstructured":"EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) (2024)"},{"key":"5436_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/BLC-200404","volume":"7","author":"A Kokorovic","year":"2021","unstructured":"Kokorovic A et al (2021) Revisiting an old conundrum: a systematic review and meta-analysis of intravesical therapy for treatment of urothelial carcinoma of the prostate. Bladder Cancer 7:243\u2013252. https:\/\/doi.org\/10.3233\/BLC-200404","journal-title":"Bladder Cancer"},{"key":"5436_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3233\/BLC-201516","volume":"7","author":"O Patschan","year":"2021","unstructured":"Patschan O et al (2021) Systematic review of the role of BCG in the treatment of urothelial Carcinoma of the Prostatic urethra. Bladder Cancer 7:213\u2013220. https:\/\/doi.org\/10.3233\/BLC-201516","journal-title":"Bladder Cancer"},{"key":"5436_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1464-410X.2008.08210.x","volume":"103","author":"ON Gofrit","year":"2009","unstructured":"Gofrit ON et al (2009) Prostatic urothelial carcinoma: Is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy? BJU Int 103:905\u2013908. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08210.x","journal-title":"BJU Int"},{"key":"5436_CR6","unstructured":"WHO classification of tumors (2022), 5th edn., Urinary and Male Genital Tumours. IARC"},{"key":"5436_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","volume":"62","author":"J Palou","year":"2012","unstructured":"Palou J et al (2012) Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 Bladder Cancer Patients Treated with Bacillus Calmette-Guerin. Eur Urol 62:118\u2013125","journal-title":"Eur Urol"},{"key":"5436_CR8","doi-asserted-by":"publisher","first-page":"239.e1","DOI":"10.1016\/j.urolonc.2018.01.018","volume":"36","author":"D Andrea","year":"2018","unstructured":"Andrea D, D, et al (2018) Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: a clinical decision-making tool. Urol Oncol 36:239.e1-239.e7. https:\/\/doi.org\/10.1016\/j.urolonc.2018.01.018","journal-title":"Urol Oncol"},{"key":"5436_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"5436_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0022-5347(05)64056-6","volume":"169","author":"B Njinou Ngninkeu","year":"2003","unstructured":"Njinou Ngninkeu B et al (2003) Transitional cell carcinoma involving the prostate. J Urol 169:149\u2013152. https:\/\/doi.org\/10.1016\/S0022-5347(05)64056-6","journal-title":"J Urol"},{"key":"5436_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.humpath.2006.01.027","volume":"37","author":"SS Shen","year":"2006","unstructured":"Shen SS et al (2006) Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 37:726\u2013734. https:\/\/doi.org\/10.1016\/j.humpath.2006.01.027","journal-title":"Hum Pathol"},{"key":"5436_CR12","doi-asserted-by":"crossref","unstructured":"Kiyoshima K, et al (2011) Depth and origin of prostatic involvement by urothelial carcinoma. JJCO 41:642\u2013646. https:\/\/pubmed.ncbi.nlm.nih.gov\/21310731\/","DOI":"10.1093\/jjco\/hyr013"},{"key":"5436_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/BLC-160086","volume":"3","author":"M Moschini","year":"2017","unstructured":"Moschini M et al (2017) Impact of the level of urothelial carcinoma involvement of the prostate on survival after radical cystectomy. Bladder Cancer 3:161\u2013169. https:\/\/doi.org\/10.3233\/BLC-160086","journal-title":"Bladder Cancer"},{"key":"5436_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/pros.23688","volume":"78","author":"R Butel","year":"2018","unstructured":"Butel R, BSc, Ball R, (2018) The distribution of BCG prostatitis: a clue for pathogenetic processes? Prostate 78:1134\u20131139. https:\/\/doi.org\/10.1002\/pros.23688","journal-title":"Prostate"},{"key":"5436_CR15","doi-asserted-by":"publisher","first-page":"9763","DOI":"10.1038\/s41598-020-66952-4","volume":"10","author":"TJ Kim","year":"2020","unstructured":"Kim TJ et al (2020) Analysis of risk factors for post-bacillus Calmette-Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer. Sci Rep 10:9763. https:\/\/doi.org\/10.1038\/s41598-020-66952-4","journal-title":"Sci Rep"},{"key":"5436_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","volume":"9","author":"JC Dudley","year":"2019","unstructured":"Dudley JC et al (2019) Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discov 9:500\u2013509. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0825","journal-title":"Cancer Discov"},{"key":"5436_CR17","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X et al (2020) Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest 130:6278\u20136289. https:\/\/doi.org\/10.1172\/JCI139597","journal-title":"J Clin Invest"},{"key":"5436_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.20.01665","volume":"39","author":"JWF Catto","year":"2021","unstructured":"Catto JWF et al (2021) Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. J Clin Oncol 39:202\u2013214. https:\/\/doi.org\/10.1200\/JCO.20.01665","journal-title":"J Clin Oncol"},{"key":"5436_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bju.14417","volume":"123","author":"A Mari","year":"2019","unstructured":"Mari A et al (2019) A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens. BJU Int 123:11\u201321. https:\/\/doi.org\/10.1111\/bju.14417","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05436-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05436-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05436-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:05Z","timestamp":1767996125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05436-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5436"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05436-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The requirement for informed consent was waived owing to the retrospective nature of this study. The study information was placed on the hospital\u2019s homepage to provide the means to opt out.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This single-center study was approved by the Institutional Review Board of Shizuoka Cancer Center (J2023-170\u20132023-1\u20133).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval of the research protocol by an institutional reviewer board"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"71"}}